![emDOCs.net – Emergency Medicine EducationEM in 5: Kawasaki Disease - emDOCs.net - Emergency Medicine Education emDOCs.net – Emergency Medicine EducationEM in 5: Kawasaki Disease - emDOCs.net - Emergency Medicine Education](http://www.emdocs.net/wp-content/uploads/2018/07/Screen-Shot-2018-07-22-at-7.23.58-PM-1024x567.png)
emDOCs.net – Emergency Medicine EducationEM in 5: Kawasaki Disease - emDOCs.net - Emergency Medicine Education
![Flow chart reference for the management of refractory and incomplete... | Download Scientific Diagram Flow chart reference for the management of refractory and incomplete... | Download Scientific Diagram](https://www.researchgate.net/publication/221845871/figure/fig1/AS:509905548976128@1498582364651/Flow-chart-reference-for-the-management-of-refractory-and-incomplete-Kawasaki-disease.png)
Flow chart reference for the management of refractory and incomplete... | Download Scientific Diagram
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the Ame
![Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5d113c51-9037-44ef-bf21-ef221a51cd49/gr1.gif)
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
![Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study - The Lancet Child & Adolescent Health Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study - The Lancet Child & Adolescent Health](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f337c396-5bb0-4b46-a6c3-6c1d02d54d8d/gr1.gif)